Haematologic Technologies, LLC
Doing business as Prolytix
At a glance
Employees20-99
In business sinceNot reported
HeadquartersEssex Junction, VT
US patents2
SAM.gov UEINBRNPENP8AG9
CAGE code3FYT9
Incorporated inDE
Brands
Background textureThis company sells these brands.
- therapeutic development
- assays
- pharmacokinetics
- biomarkers
- coagulation
- stability testing
- release testing
- method development
- process development
- monoclonal antibodies
- recombinant proteins
- plasma-derived therapies
Named on the company’s own website, read JUL 29, 2026
CareersCareers page — seen SEP 8, 2026
Supplier designations
For Profit OrganizationManufacturer of Goods
Self-certified by the company in its SAM.gov registration
Patents
2 US patents granted 1995–2009, none of them in the five years to SEP 2025.
Biotechnology 2
- Assay for tissue factor in a sampleUS 7,604,932 · granted OCT 20, 2009
- 6-peptidylamino-1-naphthalenesulfonamides useful as fluorogenic proteolytic enzyme substratesUS 5,399,487 · granted MAR 21, 1995
Granted to Haematologic Technologies, Inc. · PatentsView (USPTO), data through SEP 30, 2025 · CC BY 4.0
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Haematologic Technologies, LLC | Essex Junction | VT | 20–99 | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.